Chugai Pharmaceutical Co., Ltd. CHGCF
OTC PK
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | -7.61% | 38.78% | -- | -- | |
| Total Depreciation and Amortization | -13.32% | 2.11% | -- | -- | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 873.24% | -13.89% | -4,048.33% | -69.39% | |
| Change in Net Operating Assets | -121.55% | -25.80% | 291.18% | -72.03% | |
| Cash from Operations | -3.53% | -16.17% | 82.40% | -35.64% | |
| Capital Expenditure | 71.17% | -8,960.58% | -41.25% | -73.93% | |
| Sale of Property, Plant, and Equipment | -100.74% | 143.46% | 6,771.62% | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -372.24% | -762.53% | 75.62% | -219.16% | |
| Cash from Investing | -191.61% | -846.79% | 64.26% | -162.47% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | 23.56% | -2.58% | -- | -- | |
| Issuance of Common Stock | -100.00% | -25.00% | -42.11% | 53.33% | |
| Repurchase of Common Stock | -392,900.00% | -200.00% | 50.00% | 66.67% | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | 12.47% | -40.06% | |
| Other Financing Activities | -21.30% | -6.03% | -96.24% | 97.43% | |
| Cash from Financing | -131.33% | -9.82% | -2.43% | -38.93% | |
| Foreign Exchange rate Adjustments | -58.15% | 79.11% | 2.27% | -148.72% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -133.90% | -121.67% | 215.05% | -2,815.51% | |